Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3120.32Singapore
JB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JB.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JB.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
A.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
A.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
A.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
A.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
A.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XDK.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XDK.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XDK.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XDK.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XDK.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XDK.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XDK.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.58ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BA.2.58ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.58ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.58ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.2.58NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.58NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.58ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-3925.34Japan
BA.4.1.6ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.4.1.6ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.4.1.6ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.4.1.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.4.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.4.1.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.4.1.6ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.3.6ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.2.3.6ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.3.6ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.3.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.3.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.3.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.3.6ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
GA.10.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
GA.10.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GA.10.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GA.10.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GA.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.10.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used